Found 97 matching trials
A New Treatment Option for Heavy Menstrual Bleeding
PHASE4Women with measured menstrual bleeding \>80ml per cycle and no contraindica...
Riluzole to Treat Depression in Bipolar Disorder
PHASE2This study examines if Riluzole, FDA approved for ALS, will improve symptom...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Effects of Open-label Placebos on COVID-related Psychological Health
NAThis project aimed to test the efficacy of a telehealth-administered placeb...
Location
Michigan State University
Exenatide in Extreme Pediatric Obesity
PHASE2Extreme pediatric obesity, the fastest growing category of obesity in youth...
Location
University of Minnesota
Smoking Relapse Prevention in Schizophrenia
PHASE4This study seeks to determine if continued treatment with bupropion and nic...
Location
Freedom Trail Clinic
Open-Label Placebos to Treat Fatigue in Multiple Sclerosis
NAFatigue is one of the most prevalent and disabling symptoms of multiple scl...
Location
Tanner Foundation
Sublingual Apomorphine in Refractory Restless Legs Syndrome
PHASE4This is an open label, short placebo-controlled trial in Restless Legs Synd...
Location
Houston Methodist Hospital
A Trial of SAMe for Treatment-Resistant Bipolar Depression
NAS-adenosyl-L-methionine (SAMe) is a dietary supplement with antidepressant ...
Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder
EARLY_PHASE1The purpose of this study is to determine if translocator protein total dis...
Location
Centre for Addiction and Mental Health
Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms
NAIt has been widely recognized that the placebo effect has a profound impact...
Location
Philipps University Marburg Medical Center